PH31454A - Pharmaceutical compositions containing a staurosporine. - Google Patents
Pharmaceutical compositions containing a staurosporine.Info
- Publication number
- PH31454A PH31454A PH49409A PH49409A PH31454A PH 31454 A PH31454 A PH 31454A PH 49409 A PH49409 A PH 49409A PH 49409 A PH49409 A PH 49409A PH 31454 A PH31454 A PH 31454A
- Authority
- PH
- Philippines
- Prior art keywords
- staurosporine
- pharmaceutical compositions
- compositions containing
- dispersion
- composition
- Prior art date
Links
- HKSZLNNOFSGOKW-UHFFFAOYSA-N ent-staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(C)O1 HKSZLNNOFSGOKW-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- HKSZLNNOFSGOKW-FYTWVXJKSA-N staurosporine Chemical compound C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1[C@H]1C[C@@H](NC)[C@@H](OC)[C@]4(C)O1 HKSZLNNOFSGOKW-FYTWVXJKSA-N 0.000 title abstract 2
- CGPUWJWCVCFERF-UHFFFAOYSA-N staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(OC)O1 CGPUWJWCVCFERF-UHFFFAOYSA-N 0.000 title abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- 239000006185 dispersion Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000005456 glyceride group Chemical group 0.000 abstract 1
- 229920001515 polyalkylene glycol Polymers 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 235000003441 saturated fatty acids Nutrition 0.000 abstract 1
- 150000004671 saturated fatty acids Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939325395A GB9325395D0 (en) | 1993-12-11 | 1993-12-11 | Compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH31454A true PH31454A (en) | 1998-11-03 |
Family
ID=10746475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH49409A PH31454A (en) | 1993-12-11 | 1994-11-18 | Pharmaceutical compositions containing a staurosporine. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5736542A (da) |
| EP (1) | EP0657164B1 (da) |
| JP (1) | JPH07196512A (da) |
| KR (1) | KR100366176B1 (da) |
| AT (1) | ATE185970T1 (da) |
| AU (1) | AU692801B2 (da) |
| CA (1) | CA2137764C (da) |
| DE (1) | DE69421366T2 (da) |
| DK (1) | DK0657164T3 (da) |
| ES (1) | ES2140512T3 (da) |
| GB (1) | GB9325395D0 (da) |
| GR (1) | GR3032368T3 (da) |
| IL (1) | IL111872A (da) |
| NZ (1) | NZ270109A (da) |
| PH (1) | PH31454A (da) |
| PT (1) | PT657164E (da) |
| ZA (1) | ZA949824B (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6200968B1 (en) | 1998-08-06 | 2001-03-13 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
| US7795246B2 (en) | 1998-08-06 | 2010-09-14 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
| US6242473B1 (en) * | 1999-01-08 | 2001-06-05 | Maxim Pharmaceuticals, Inc. | Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| GB9903547D0 (en) * | 1999-02-16 | 1999-04-07 | Novartis Ag | Organic compounds |
| DE19917990A1 (de) * | 1999-04-20 | 2000-11-02 | Florian Lang | Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk |
| AU6014900A (en) | 1999-07-13 | 2001-01-30 | Kyowa Hakko Kogyo Co. Ltd. | Staurosporin derivatives |
| DE10042137A1 (de) * | 2000-08-28 | 2002-03-14 | Florian Lang | sgk2 und sgk3 als diagnostische und therapeutische Targets |
| WO2002076432A2 (en) * | 2001-03-26 | 2002-10-03 | Novartis Ag | Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer |
| WO2004079003A1 (de) * | 2003-03-03 | 2004-09-16 | Florian Lang | Sgk1 als diagnostisches und therapeutisches target |
| US20040246627A1 (en) * | 2003-06-06 | 2004-12-09 | Durrum Thomas M. | Disc drive pivot bearing assembly |
| EP1653973A1 (en) | 2003-08-08 | 2006-05-10 | Novartis AG | Combinations comprising staurosporines |
| KR101152470B1 (ko) | 2003-08-13 | 2012-06-01 | 바이오콘 리미티드 | 치료제용 마이크로-입자 지방산 염 고형 투약 제형 |
| EP1856522A1 (en) * | 2005-02-07 | 2007-11-21 | TopoTarget UK Limited | Assays for agents with selective cytotoxicty to hdac resistant cell lines |
| US20100168219A1 (en) * | 2008-12-31 | 2010-07-01 | Jonathan Steven Alexander | Chronic inflammation and transplantation |
| US9994585B2 (en) | 2007-12-31 | 2018-06-12 | Aphios Corporation | Transplantation therapies |
| US9034347B2 (en) | 2011-12-19 | 2015-05-19 | Arphios Corporation | Drug delivery system and method for the treatment of neuro-degenerative disease |
| JP6579956B2 (ja) | 2012-11-28 | 2019-09-25 | アフィオス コーポレーション | 神経変性疾患および他の疾患の治療のための併用治療薬および方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60185719A (ja) * | 1984-03-06 | 1985-09-21 | Ajinomoto Co Inc | 抗腫瘍剤 |
| JPH0699311B2 (ja) * | 1986-11-06 | 1994-12-07 | 旭化成工業株式会社 | 抗血管レン縮剤および血管弛緩剤 |
| IL86632A0 (en) * | 1987-06-15 | 1988-11-30 | Ciba Geigy Ag | Derivatives substituted at methyl-amino nitrogen |
| US5093330A (en) * | 1987-06-15 | 1992-03-03 | Ciba-Geigy Corporation | Staurosporine derivatives substituted at methylamino nitrogen |
| JPH01143877A (ja) * | 1987-11-30 | 1989-06-06 | Asahi Chem Ind Co Ltd | スタウロスポリン誘導体 |
| EP0383919A4 (en) * | 1988-02-04 | 1992-08-05 | Kyowa Hakko Kogyo Co., Ltd. | Staurosporin derivatives |
| JPH0725786A (ja) * | 1990-05-16 | 1995-01-27 | Univ Rockefeller | アルツハイマー病を伴うアミロイドーシスの治療 |
| EP0577769A4 (en) * | 1991-03-29 | 1994-06-01 | Us Commerce | Pharmaceutical compositions and methods for preventing skin tumor formation and causing regression of existing tumors |
| JPH0597708A (ja) * | 1991-10-02 | 1993-04-20 | Lion Corp | 歯周病治療剤 |
| EP0540185A1 (en) * | 1991-10-10 | 1993-05-05 | Schering Corporation | 4'-(N-substituted-N-oxide)staurosporine derivatives |
| JPH05247055A (ja) * | 1992-03-03 | 1993-09-24 | Meiji Seika Kaisha Ltd | スタウロスポリン誘導体及びそれを含有する抗腫瘍効果増強剤 |
-
1993
- 1993-12-11 GB GB939325395A patent/GB9325395D0/en active Pending
-
1994
- 1994-11-18 PH PH49409A patent/PH31454A/en unknown
- 1994-11-22 US US08/343,404 patent/US5736542A/en not_active Expired - Fee Related
- 1994-12-02 EP EP94308954A patent/EP0657164B1/en not_active Expired - Lifetime
- 1994-12-02 AT AT94308954T patent/ATE185970T1/de active
- 1994-12-02 DE DE69421366T patent/DE69421366T2/de not_active Expired - Lifetime
- 1994-12-02 DK DK94308954T patent/DK0657164T3/da active
- 1994-12-02 ES ES94308954T patent/ES2140512T3/es not_active Expired - Lifetime
- 1994-12-02 PT PT94308954T patent/PT657164E/pt unknown
- 1994-12-05 IL IL111872A patent/IL111872A/en not_active IP Right Cessation
- 1994-12-08 AU AU80308/94A patent/AU692801B2/en not_active Ceased
- 1994-12-09 ZA ZA949824A patent/ZA949824B/xx unknown
- 1994-12-09 CA CA002137764A patent/CA2137764C/en not_active Expired - Fee Related
- 1994-12-09 NZ NZ270109A patent/NZ270109A/en not_active IP Right Cessation
- 1994-12-09 KR KR1019940033397A patent/KR100366176B1/ko not_active Expired - Fee Related
- 1994-12-12 JP JP6307534A patent/JPH07196512A/ja active Pending
-
2000
- 2000-01-14 GR GR20000400066T patent/GR3032368T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0657164T3 (da) | 2000-04-17 |
| JPH07196512A (ja) | 1995-08-01 |
| CA2137764C (en) | 2006-02-07 |
| KR960021018A (ko) | 1996-07-18 |
| EP0657164B1 (en) | 1999-10-27 |
| CA2137764A1 (en) | 1995-06-12 |
| IL111872A (en) | 1998-02-08 |
| ES2140512T3 (es) | 2000-03-01 |
| ZA949824B (en) | 1995-07-13 |
| DE69421366T2 (de) | 2000-03-23 |
| GB9325395D0 (en) | 1994-02-16 |
| KR100366176B1 (ko) | 2003-03-03 |
| US5736542A (en) | 1998-04-07 |
| AU692801B2 (en) | 1998-06-18 |
| ATE185970T1 (de) | 1999-11-15 |
| DE69421366D1 (de) | 1999-12-02 |
| PT657164E (pt) | 2000-04-28 |
| AU8030894A (en) | 1995-06-22 |
| IL111872A0 (en) | 1995-06-29 |
| NZ270109A (en) | 1996-11-26 |
| GR3032368T3 (en) | 2000-04-27 |
| EP0657164A1 (en) | 1995-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU692801B2 (en) | Pharmaceutical compositions comprising a staurosporine as active ingredient. | |
| ES2186715T3 (es) | Uso de un tensioactivo lipofilico en una composicion farmaceutica. | |
| AU601176B2 (en) | Benzodiazepine aerosols | |
| NZ243062A (en) | Aerosol containing medicament and 1,1,1,2-tetrafluoroethane | |
| HK57196A (en) | Cyclosporin compositions for oral administration | |
| LV11884A (lv) | Ciklosporina oralas arstnieciskas formas ar augstu biopieejamibu | |
| GR3005191T3 (da) | ||
| WO2000009639A3 (en) | Fatty ester combinations | |
| EP0451461A3 (en) | Use of mixtures of polyglycerol fatty acid esters as emulsifiers in cosmetic and pharmaceutical compositions | |
| WO1992017077A3 (en) | Fat substitute compositions having reduced laxative effects | |
| HU896123D0 (en) | Pharmaceutical compositions | |
| EP0368339A3 (en) | Pharmaceutical preparation for percutaneous administration containing bunazosin or its salt | |
| MY120521A (en) | Pharmaceutical microspheres of valproic acid for oral administration. | |
| IL109534A (en) | Pour-on formualtions of avermectin derivatives containing mixed caprylic/capric acid esters of propylene glycol or glycerol as carrier | |
| NZ330062A (en) | composition containing cyclosporin, propylene carbonate, an oil component and a surfactant | |
| IL86395A (en) | Pharmaceutical compositions with improved bioavailability containing flunarizine and polyethoxylated castor oil | |
| IL105215A0 (en) | 9-fluoro-7-oxo-7h-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acids and their esters,their preparation and pharmaceutical compositions containing them | |
| WO1995023586A3 (de) | Kosmetische und/oder pharmazeutische zubereitungen | |
| WO1999008666A3 (en) | Pharmaceutical composition comprising an azateroid | |
| IL105214A0 (en) | 7-oxo-7h-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acids and their esters,their preparation and pharmaceutical compositions containing them | |
| DE3484606D1 (en) | Deodorant. | |
| JPS6429317A (en) | Local administration composition for treating fungal infection | |
| JPS5772908A (en) | Removing agent for make-up cosmetic | |
| RU99121398A (ru) | Фармацевтические композиции | |
| JPS5640607A (en) | Drug composition |